KTTA
Price
$1.74
Change
+$0.01 (+0.58%)
Updated
Apr 28, 02:20 PM (EDT)
Capitalization
4.68M
TRAW
Price
$1.54
Change
-$0.01 (-0.65%)
Updated
Apr 28, 02:46 PM (EDT)
Capitalization
7.86M
Ad is loading...

KTTA vs TRAW

Header iconKTTA vs TRAW Comparison
Open Charts KTTA vs TRAWBanner chart's image
Pasithea Therapeutics
Price$1.74
Change+$0.01 (+0.58%)
Volume$459
Capitalization4.68M
Traws Pharma
Price$1.54
Change-$0.01 (-0.65%)
Volume$100
Capitalization7.86M
KTTA vs TRAW Comparison Chart
Loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KTTA vs. TRAW commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTTA is a Buy and TRAW is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (KTTA: $1.73 vs. TRAW: $1.55)
Brand notoriety: KTTA and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KTTA: 7% vs. TRAW: 102%
Market capitalization -- KTTA: $4.68M vs. TRAW: $7.86M
KTTA [@Biotechnology] is valued at $4.68M. TRAW’s [@Biotechnology] market capitalization is $7.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KTTA’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 0 green FA rating(s).

  • KTTA’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 0 green, 5 red.
According to our system of comparison, KTTA is a better buy in the long-term than TRAW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 6 TA indicator(s) are bullish while TRAW’s TA Score has 4 bullish TA indicator(s).

  • KTTA’s TA Score: 6 bullish, 2 bearish.
  • TRAW’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than TRAW.

Price Growth

KTTA (@Biotechnology) experienced а +25.36% price change this week, while TRAW (@Biotechnology) price change was -21.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.75%. For the same industry, the average monthly price growth was +0.72%, and the average quarterly price growth was -9.37%.

Reported Earning Dates

KTTA is expected to report earnings on Mar 24, 2025.

TRAW is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRAW($7.86M) has a higher market cap than KTTA($4.68M). KTTA YTD gains are higher at: -45.079 vs. TRAW (-82.545). KTTA has higher annual earnings (EBITDA): -15.49M vs. TRAW (-24.08M). KTTA has more cash in the bank: 9.36M vs. TRAW (5.41M). TRAW has higher revenues than KTTA: TRAW (226K) vs KTTA (0).
KTTATRAWKTTA / TRAW
Capitalization4.68M7.86M60%
EBITDA-15.49M-24.08M64%
Gain YTD-45.079-82.54555%
P/E RatioN/AN/A-
Revenue0226K-
Total Cash9.36M5.41M173%
Total Debt0N/A-
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KTTATRAW
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPOR175.003.65
+2.13%
Gulfport Energy Corp
MDV16.640.33
+2.02%
Modiv Industrial
SWK61.58-0.34
-0.55%
Stanley Black & Decker
TMP59.22-0.43
-0.72%
Tompkins Financial Corp
DGLY0.03N/A
-2.43%
Digital Ally

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+0.58%
FATE - KTTA
32%
Poorly correlated
-5.19%
ACET - KTTA
25%
Poorly correlated
-4.62%
SPRB - KTTA
24%
Poorly correlated
-7.22%
TRAW - KTTA
24%
Poorly correlated
+1.31%
HEPA - KTTA
24%
Poorly correlated
-0.86%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
+1.31%
SLGL - TRAW
52%
Loosely correlated
+0.80%
RAPT - TRAW
45%
Loosely correlated
+0.48%
MDGL - TRAW
39%
Loosely correlated
+2.14%
CYTK - TRAW
36%
Loosely correlated
+0.25%
AVXL - TRAW
34%
Loosely correlated
-0.32%
More